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behind the retrohepatic segment of the inferior
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Background: Resection of a retrocaval paraganglioma is technically challenging due to limited tumor accessibility
and proximity to the vena cava.
Case presentation: A large, malignant paraganglioma was found behind the retrohepatic segment of the inferior
vena cava of a 60-year-old male. During resection of this rare paraganglioma, the left lateral lobe of the liver, a
portion of the caudate lobe of the liver, and the gallbladder were also removed. Unfortunately, the patient died six
months after surgery due to hepatic metastasis.
Conclusion: This case demonstrates that a partial hepatectomy may be necessary to improve tumor accessibility
during resection of a retrocaval paraganglioma, particularly if the tumor is proximal to the vena cava. Furthermore,
palliative treatments may help prevent tumor recurrence and metastasis of malignant paragangliomas.
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Paragangliomas, also known as extra-adrenal pheochro-
mocytomas, are rare. Moreover, they are usually benign,
catecholamine-secreting tumors that arise from chromaf-
fin cells of the sympathetic ganglia [1]. Although most
paragangliomas are located along the para-aortic sympa-
thetic chains in the urinary bladder, thoracic cavity, or
head and neck, they have also been found to develop in
other regions of the body [2]. Resection of paragangliomas
can be difficult, due to the complex anatomy and intensive
intraoperative hemodynamic control needed, particularly
as retrocaval paragangliomas often develop in proximity of
the vena cava [3,4]. Correspondingly, meticulous surgical
procedures are required for resection of these tumors. In
addition, these surgeries are often associated with a high
risk of damage to adjacent organs or blood vessels. Al-
though several reports have described the successful resec-
tion of retrocaval paragangliomas [3-6], these tumors were
either relatively small (< 5 cm) or were located near renal
veins.* Correspondence: daicl_sj@163.com
1Department of General Surgery, China Medical University, 110004 Shenyang,
Liaoning Province, P.R. China
Full list of author information is available at the end of the article
© 2013 Jia et al.; licensee BioMed Central Ltd.
Commons Attribution License (http://creativec
reproduction in any medium, provided the orHere, a rare malignant paraganglioma located behind
the retrohepatic segment of the inferior vena cava (IVC)
is described. By performing a partial hepatectomy, the
retrocaval tumor was successfully resected without by-
pass of the vena cava.Case presentation
A 60-year-old man presented with a 2-month history of
persistent right epigastric pain and a weight loss of 9 kg,
without fever, headaches, palpitations, and sweating at-
tacks. His two brothers had previously died of esopha-
geal cancer and gastric cancer. At a local hospital, a
computed tomography (CT) scan without using contrast
medium revealed a large retroperitoneal mass that was
characterized by a non-homogeneous appearance and
slightly low density. Magnetic resonance imaging showed
both hypo- and hyper-signal intensities on T1-weighted
images, whereas only hyper-signal intensity was observed
on T2-weighted images. Compression of the hepatic seg-
ment of the IVC was also observed. Due to the complex
anatomy of the tumor region and the need for resection,
the patient was referred to a tertiary unit for further onco-
logical and surgical assessment.This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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hypertension or any other cardiovascular disease. A gen-
eral physical examination findings were normal. The
patient’s blood pressure varied at normal level (110-130/
69-86 mmHg). Blood and urine analyses, liver and
kidney function, and clotting time, were also normal.
The patient’s fasting blood glucose level was 7.34 mmol/
L (reference range: 3.9–6.11 mmol/L) and glycosylated
hemoglobin level was 7.2 mg/ dL. Serum levels of tumor
markers, including carcinoembryonic antigen, alpha-
fe-toprotein, and carbohydrate, were normal. Preoperative
levels of adrenocorticotropic hormone were assayed at
various time points: 15.98 pg/mL at 0:00, 20.25 pg/mL at
8:00, and 14.40 pg/mL at 16:00. Plasma renin activity was
1.30 ng/mL (0.05–2.86 in the lying position), angiotensin
II was 31.50 pg/mL (16.2–64.2, lying down), aldosterone
was 91.00 pg/mL (59–174, lying down), and serum levels
of cortisol were 7.95 μg/dL at 0:00, 14.53 μg/dL at 8:00,
and 6.44 μg/dL at 16:00. Levels of vanillylmandelic acid
and urine volume after 24 h were 31.41 mg (1.4–6.5 mg)
and 2.05 L, respectively.
Ultrasonography revealed a 7.4 cm× 4.5 cm well-
demarcated solid mass with mixed echoes (a mosaic of
medium and low signals) located between the upper ab-
dominal IVC and the aortic artery (Figure 1A). The hepatic
segment of the IVC was also compressed and shifted
forward. A contrast-enhanced CT with 3D reconstructionFigure 1 Diagnostic imaging of the retroperitoneal
paraganglioma. (A) Abdominal ultrasonography showed a
retrocaval mass (indicated by arrowheads) present in the right
parasagittal sonographic section. The mass compressed the IVC
(indicated by an white arrow) in an anterior direction. (B) Axial
contrast-enhanced CT scan showed a non-homogeneously
enhanced retrocaval mass (indicated by arrowheads) with necrotic
cysts. (C) Coronal contrast-enhanced CT scan showed anterior
displacement and extrinsic compression of the IVC (indicated by an
black arrow) by the retrocaval mass (indicated by arrowheads).
(D) Postoperative abdominal US scan showed multifocal hepatic
metastatic lesions (shown in blue).scan showed a 6.5 cm× 4.8 cm mass with non-
homogeneous density located behind the retrohepatic
segment of the IVC (Figure 1B&C). The mass was well-
delineated, exhibited non-homogeneous enhancement with
multiple necrotic cysts, and the adjacent lymph nodes were
not swollen. Compression of the right adrenal gland, caud-
ate lobe, and IVC, and invasion of the right side of the
diaphragm horn were also observed. The retrohepatic
segment of the IVC was mostly compressed, with the left
vessel wall attached to the mass. There was no clear bound-
ary between the left vessel wall and the mass. In addition,
there were no filling defects visualized in the vessel lumen,
and no distant metastasis was detected. Thus, a preopera-
tive diagnosis of primary retroperitoneal tumor (except for
normotensive ectopic pheochromocytoma) was made.
Prior to undergoing a laparotomy, the patient com-
pleted 3-day volume expansion therapy with artificial
colloid solution. During surgical exploration, a generous
right subcostal incision was made. The mass of interest
was found behind the retrohepatic portion of the IVC.
The adjacent lymph nodes were not swollen. Compres-
sion of the IVC was observed, with the hepatic hilum
lifted in an anterior direction (Figure 2A). The tumor
and retrohepatic portion of the IVC were fully exposed
by resection of the hepatic left lateral lobe. The tumor
was identified from the renal level to the second hepatic
hilum, and a portion of the caudate lobe was found toFigure 2 Intraoperative imaging of the retroperitoneal
paraganglioma. (A) The tumor (indicated by arrowheads) was
found behind the retrohepatic segment of the IVC with the hepatic
hilum (indicated by an white arrow) lifted in an anterior direction.
(B) After the gallbladder and the hepatic left lateral lobe were
resected, the IVC (indicated by an black arrow) was carefully
mobilized clockwise in a cephalad and dorsal direction up to the
level of the second hepatic hilum via a left lateral side approach.
(C) After the tumor was removed, the IVC (indicated by an black
arrow) and the prevertebral space become fully visible.
(D) Specimen of the retroperitoneal paraganglioma.
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caudate lobe were resected, and extensive dissection of
the IVC followed. Briefly, the IVC was carefully mobi-
lized clockwise in a cephalad and dorsal direction up to
the level of the second hepatic hilum via a left lateral
side approach. Finally, the prevertebral space was di-
vided carefully behind the tumor, and a portion of the
affected diaphragm tissue on the right side, as well as
the surrounding diaphragmatic muscle, were removed
(Figure 2B&C). Thus, the tumor was successfully re-
moved along with the left lateral lobe of the liver, a por-
tion of the caudate lobe of the liver, and the gallbladder.
Intraoperatively, there was two sharp changes in
hemodynamic status of the patients observed during
manipulation of the tumour (blood pressure rose to 150-
160/90-100 mmHg), which was treated with nicardipine
hydrochloride and sodium nitroprusside. Esmolol hy-
drochloride was used to decrease the heart rate. After
the tumor was resected, the blood pressure dropped to
70/50 mmHg and norepinephrine was pumped continu-
ously one half hour. Blood pressure rose and steadied at
110/85 mmHg in the end.
The resected tumor (8 cm × 6 cm × 4 cm) was solid,
nodular, and encapsulated. On the tumor surface, many
tortuous vessels and some localized necrotic tissue were
observed (Figure 2D). Macroscopically, tumor invasion
into the liver and the adrenal gland was not apparent.
However, microscopically, the tumor was found to have
invaded the caudate lobe. Histological analysis identified
alveolar-like structures with many vascular septa within
the tumor (Figure 3A). In addition, the tumor cells con-
tained fine eosinophilic granules, while cell mitosis and
nuclear atypia were infrequent. Immunohistochemical
analyses demonstrated that the tumor cells were ne-
gative for α-smooth muscle actin (SMA), and positive
for chromogranin A (CgA), synaptophysin (Syn), S-100,
cytokeratin (CK), and CD34 (Figure 3B&C).
By 3 days after surgery, the patient undergone closed
thoracic drainage for the right side of massive pleural
effusion and aerothorax with the obviously compression
of the right lung. The closed thoracic drainage tube wasFigure 3 Histological and immunohistochemical analyses of the retro
resected specimen (magnification, 100×; scale bar = 100 μm). (B and C) Im
(C) synaptophysin (magnification, 400×; scale bar = 50 μm).removed on postoperative day 18 and the patient was
discharged on postoperative day 21. Postoperative adju-
vant chemotherapy CVD-protocol (cyclophosphamide
750 mg/m2, vincristine 1.4 mg/m2, and dacarbazine
600 mg/m2 on Day 1 and dacarbaine 600 mg/m2 on Day 2;
every 21 to 28 days) was recommended; however, the
patient refused. During the follow-up period, the patient’s
initial symptoms of paraganglioma rapidly disappeared.
However, 3 months later, ultrasonography revealed hepatic
metastasis (Figure 1D). The patient refused any other treat-
ment and died 3 months later.
Discussion
Paragangliomas can develop anywhere along the midline
of the retroperitoneum. The exact incidence of retro-
peritoneal paragangliomas is unknown, although males
are typically affected more frequently than females. In
addition, most patients are diagnosed between 30 and
45 years of age [7]. Clinically, patients with a retroperi-
toneal paraganglioma often present with back pain or a
palpable mass [8]. Approximately 10% of cases have
distant metastases detected at the time of diagnosis [9].
Only a subset of paragangliomas is clinically functional
and often exhibit signs and symptoms consistent with
actively secretion of catecholamine, including headaches,
sweating, palpitation, and hypertension [7]. The present
case represents a rare normotensive malignant paragan-
glioma that developed in a relatively aged man, only
presented with abdominal pain.
Based on an increase in the level of urine vanillylman-
delic acid after 24 h and sharp fluctuation of intraopera-
tive blood pressure, the normotensive paraganlioma is
functional in the present case. Prior to the resection of
pheochromocytoma or paraganglioma, alpha blocker is
still recommended. However, the effect has never been
tested in a randomized clinical trial. The necessity of
preoperative alpha blocker remains uncertain for the
normotensive or asymptomatic pheochromocytom [10].
Shao et al. [11] considered that preoperative alpha-
adrenoceptor antagonist didn’t have benefit in maintain-
ing intraoperative hemodynamic stability in patients withperitoneal paraganglioma. (A) Hematoxylin and eosin staining of the
munohistochemical staining for (B) S100 protein and
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use of vasoactive drugs and colloid infusion. Groeben
et al. [12] also reported that there was no correlation be-
tween the individual dose of phenoxybenzamine and the
maximum blood pressure in 200 consecutive resections
of catecholamine-producing tumors. In the present case,
alpha-blocker wasn’t used prior to the operation. Al-
though the intraoperative blood pressure varied sharply,
there wasn’t malignant hypertension. The operation and
anaesthesia process were controllable, which may be re-
lated with the improvement of surgical techniques, diag-
nostic tools and highly effective short acting substances
to control hemodynamics intraoperatively [12].
Conventional treatment for paragangliomas typically
involves complete surgical excision, while surgical de-
bulking is considered a mainstay of palliative therapy for
malignant paragangliomas [13]. In some cases, complete
excision is difficult due to the highly vascular nature of
paragangliomas and their proximity to major blood ves-
sels. While some authors have reported the successful
resection of retrocaval paragangliomas with or without
the need for vena cava reconstruction [3-6], the location
of the present paraganglioma behind the retrohepatic
portion of the IVC made it difficult to resect the tumor
completely. A combined partial hepatectomy was per-
formed to observe the relationship between the tumor
and IVC directly. If extensive invasion of the IVC has
occurred, vena cava repair or reconstruction may be re-
quired [5]. Moreover, if the IVC is completely occluded
due to compression and invasion by a tumor, the IVC
can be ligated after tumor resection [5]. If the tumor is
large and extends across the entire region of the retrohe-
patic IVC, or invades surrounding liver tissue as ob-
served in the present case, then a combined partial
hepatectomy may be more suitable. Although both lap-
aroscopic and open resection of retroperitoneal paragan-
gliomas are possible, a retrocaval tumor > 5 cm is not
considered a candidate for laparoscopic surgery [3].
Although paragangliomas are usually benign, 30–50%
of all retroperitoneal paragangliomas are malignant
[14]. No definitive tests are currently available to differ-
entiate between benign and malignant paragangliomas.
Malignancy can often only be confirmed by detecting
local invasion of surrounding structures upon examin-
ation at the time of resection, or by detecting the
presence of metastases [1]. Furthermore, although
histological and immunohistochemical findings do not
permit a definitive diagnosis of malignancy, several
factors have been associated with malignancy. These
include a tumor weight > 80 g, high concentration of
dopamine proximal to the tumor, tumor size > 5 cm,
presence of confluent tumor necrosis, and a younger
patient age [15]. In the present case, tumor invasion
into the caudate lobe of the liver was observedmicroscopically, and hepatic metastasis was detected in
the postoperative follow-up period.
Although en bloc resection was performed to remove
the affected surrounding hepatic lobe and diaphragm
tissue, it did not extend the life of the patient. Had the
malignant nature of the tumor been identified, then the
pharmacologic control of symptoms, targeted methods,
and systemic antineoplastic therapy could have been ap-
plied [16]. The most effective chemotherapy regime is the
CVD-protocol, as partial - and in few cases complete-
response in up to 50-55% of the patients [17]. In contrast,
palliative treatments for patients with advanced paragan-
gliomas remain limited [1].
Conclusions
Here, we report an extremely rare case of malignant
paraganglioma, in which the tumor was located behind
the retrohepatic segment of the IVC. The paraganglioma
was successfully resected, along with the left lateral lobe
and caudate lobe of the liver. This case demonstrates
that a partial hepatectomy can improve tumor accessibil-
ity, particularly if the tumor is proximal to the vena cava.
In addition, palliative treatments may help prevent post-
operative tumor recurrence and metastasis.
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